4Chen CH, Wen HJ, Chen PC, et al. Prenatal and postnatal risk factors for infantile pneumonia in a representative birth cohort[ J]. Epidemiol Infect, 2012, 140(7) : 1277 -1285.
5Altman KW, Prufer N, Vaezi MF. The challenge of protocols for reflux disease: a review and development of a critical pathway[ J]. Otolaryngol Head Neck Surg, 2011, 145 ( 1 ) : 7 - 14.
6Kukulka M, Nudurupati S, Perez MC. Pharmacokinetics and safe- ty of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease [ J ]. Clin Exp Gastroenterol, 2014.7:461 -471.
7Hegar B. Gastroesophageal reflux in infants[ J]. Southeast Asian J Trop Med Public Health, 2014, 45(Suppl 1) : 69 -72.
8Perry KA, Pharn TH, Spechler SJ, et al. 2014 SSAT State - of- the - Art Conference: advances in diagnosis and management of gastroesophageal reflux disease [ J ]. J Gastrointest Surg, 2015, 19 (3) : 458 -466.
9Hegar B, Satari DH, Sjarif DR, et al. Regurgitation and gastroe- sophageal reflux disease in six to nine months old indonesian infants [ J ]. Pediatr Gastroenterol Hepatol Nutr, 2013, 16 (4) : 240 - 247.
